Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women

Journal of Infectious Diseases

Volumn 187, Issue 9, 2003, Pages 1388-1396

  Stover, Cynthia T ^a,c   Smith, Dawn K ^b   Schmid, D Scott ^c   Pellett, Philip E ^c   Stewart, John A ^c   Klein, Robert S ^d   Mayer, Kenneth ^f   Vlahov, David ^e   Schuman, Paula ^g   Cannon, Michael J ^c,h  

^a EMORY UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e NEW YORK ACADEMY OF MEDICINE   (United States)

^f BROWN UNIVERSITY   (United States)

^g WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; CYTOMEGALOVIRUS; DNA DETERMINATION; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SEROPREVALENCE; VIRUS INFECTION;

ADOLESCENT; ADULT; AGE FACTORS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ETHNIC GROUPS; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK FACTORS; SEXUAL BEHAVIOR; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; VIRUS DISEASES;

EID: 0037541570     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/374649     Document Type: Article

References (43)

1. McQuillan GM, Khare M, Karon J, Schable CA, Vlahov D. Update on the seroepidemiology of human immunodeficiency virus in the United States household population: NHANES III, 1988-1994. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:355-60.
2. Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health 1996; 86:642-54.
3. Karon JM, Fleming PL, Steketee RW, De Cock KM. HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health 2001; 91:1060-8.
4. Centers for Disease Control and Prevention. HIV AIDS Surveill Rep 2000; 12:1-41.
5. Cates W Jr. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis 1999; 26:S2-7.
6. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Morb Mortal Wkly Rep 1998; 47(RR-19):1-39.
7. Drew WL. Cytomegalovirus infection in patients with AIDS. Clin Infect Dis 1992; 14:608-15.
8. Demmler GJ. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Infectious Diseases Society of America, Centers for Disease Control and Prevention. Rev Infect Dis 1991; 13:315-29.
9. Sarid R, Olsen SJ, Moore PS. Kaposi's sarcoma-associated herpesvirus: epidemiology, virology, and molecular biology. Adv Virus Res 1999; 52:139-232.
10. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338:423-8.
11. Holmberg SD, Stewart JA, Gerber AR, et al. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA 1988; 259:1048-50.
12. Holmberg SD, Gerber AR, Stewart JA, Byers RH, Nahmias AJ. Herpes simplex virus type 2 and HIV seroconversion. J Acquir Immune Defic Syndr 1991; 4:732-4.
13. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556-62.
14. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337:1105-11.
15. McQuillan GM, Coleman PJ, Kruszon-Moran D, Moyer LA, Lambert SB, Margolis HS. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health 1999; 89:14-8.
16. Xu F, Schillinger JA, Sternberg MR, et al. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. J Infect Dis 2002; 185:1019-24.
17. Smith DK, Warren DL, Vlahov D, et al. Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: a prospective cohort study of human immunodeficiency virus infection in US women. Am J Epidemiol 1997; 146:459-69.
18. Waner JL, Stewart JA. Cytomegalovirus. In: Rose NR, DeMarco EC, Fahey JL, Friedman H, eds. Manual of clinical laboratory immunology. 4th ed. Washington, DC: American Society for Microbiology Press, 1992:563-7.
19. Pau CP, Lam LL, Spira TJ, et al. Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein. J Clin Microbiol 1998; 36:1574-7.
20. Spira TJ, Lam L, Dollard SC, et al. Comparison of serologic assays and PCR for the diagnosis of human herpesvirus 8 (HHV-8) infection. J Clin Microbiol 2000; 38:2174-80.
21. Schmid DS, Brown DR, Nisenbaum R, et al. Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2. J Clin Microbiol 1999; 37:376-9.
22. Jamieson DJ, Duerr A, Burk R, et al. Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection. Am J Obstet Gynecol 2002; 186:21-7.
23. Ahdieh L, Klein RS, Burk R, et al. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis 2001; 184:682-90.
24. Cannon MJ, Dollard SC, Smith DK, et al. Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med 2001; 344:637-43.
25. Ho GY, Burk RD, Fleming I, Klein RS. Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer 1994; 56:788-92.
26. Kleinbaum DG. Modeling strategy guidelines. In: Logistic regression: a self-learning text. New York: Springer-Verlag, 1994:161-90.
27. Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999; 341:1432-8.
28. Chandler SH, Holmes KK, Wentworth BB, et al. The epidemiology of cytomegaloviral infection in women attending a sexually transmitted disease clinic. J Infect Dis 1985; 152:597-605.
29. Division of STD Prevention, Centers for Disease Control and Prevention (CDC). Sexually transmitted disease surveillance, 1996. Atlanta: CDC, 1997.
30. Thomas DL, Rich JD, Schuman P, et al. Multicenter evaluation of hepatitis C RNA levels among female injection drug users. J Infect Dis 2001; 183:973-6.
31. Rodriguez-Rosado R, Perez-Olmeda M, Garcia-Samaniego J, Soriano V. Management of hepatitis C in HIV-infected persons. Antiviral Res 2001; 52:189-98.
32. Herrero ME. Hepatitis B and hepatitis C co-infection in patients with HIV. Rev Med Virol 2001; 11:253-70.
33. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3-17.
34. Wasserheit JN. Epidemiological synergy: interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992; 19:61-77.
35. Augenbraun M, Corey L, Reichelderfer P, et al. Herpes simplex virus shedding and plasma human immunodeficiency virus RNA levels in coinfected women. Clin Infect Dis 2001; 33:885-90.
36. Hook EW III, Cannon RO, Nahmias AJ, et al. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis 1992; 165:251-5.
37. Thomas DL, Cannon RO, Shapiro CN, Hook EW III, Alter MJ, Quinn TC. Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis 1994; 169:990-5.
38. Goldstein ST, Alter MJ, Williams IT, et al. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. J Infect Dis 2002; 185:713-9.
39. Peyton CL, Gravitt PE, Hunt WC, et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis 2001; 183:1554-64.
40. Burk RD, Kelly P, Feldman J, et al. Declining prevalence of cervico-vaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 1996; 23:333-41.
41. Corey L, Spear PG. Infections with herpes simplex viruses (2). N Engl J Med 1986; 314:749-57.
42. Johnson RE, Nahmias AJ, Magder LS, Lee FK, Brooks CA, Snowden CB. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med 1989; 321:7-12.
43. Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992; 116:197-202.